Imaging of medullary thyroid cancer with 131I-MIBG.

Suppr

超能文献

作者信息

Endo K, Shiomi K, Kasagi K, Konishi J, Torizuka K, Nakao K, Tanimura H

出版信息

Lancet. 1984 Jul 28;2(8396):233. doi: 10.1016/s0140-6736(84)90525-7.

DOI:10.1016/s0140-6736(84)90525-7

PMID:6146795

Abstract

摘要

相似文献

Imaging of medullary thyroid cancer with 131I-MIBG.

Lancet. 1984 Jul 28;2(8396):233. doi: 10.1016/s0140-6736(84)90525-7.

Detection of metastatic medullary thyroid cancer with 131I-MIBG scans in Sipple's syndrome.

Eur J Nucl Med. 1986;11(12):502-4. doi: 10.1007/BF00252798.

Pitfall of Sipple's syndrome diagnosis by 131I-metaiodobenzylguanidine (MIBG).

J Nucl Med Allied Sci. 1987 Oct-Dec;31(4):337-40.

Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.

Nucl Med Commun. 1986 Apr;7(4):215-21. doi: 10.1097/00006231-198604000-00003.

Imaging and uptake mechanism of 131I-meta-iodobenzylguanidine in medullary thyroid carcinoma.

Endocrinol Jpn. 1986 Jun;33(3):309-15. doi: 10.1507/endocrj1954.33.309.

Thyroid uptake of MIBG in Sipple's syndrome.

Eur J Nucl Med. 1988;14(1):37-8. doi: 10.1007/BF00252616.

Iodine-131 MIBG uptake in metastatic medullary carcinoma of the thyroid. A patient treated with somatostatin.

Clin Nucl Med. 1988 Apr;13(4):260-3. doi: 10.1097/00003072-198804000-00007.

[Clinical applications of 131I-meta iodobenzylguanidine (131I-MIBG) scintigraphy in Japan].

Kaku Igaku. 1986 Feb;23(2):145-52.

Medullary thyroid carcinoma: localization of a mediastinal metastasis with I-131 MIBG.

Clin Nucl Med. 1988 Aug;13(8):577-9.

[The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].

Kaku Igaku. 1992 Sep;29(9):1083-98.

引用本文的文献

Incidental Detection of Synchronous Medullary Thyroid Carcinoma with Bilateral Adrenal Pheochromocytoma on Iodine-123 Metaiodobenzylguanidine Scintigraphy, Leading to Diagnosis of Multiple Endocrine Neoplasia 2A.

World J Nucl Med. 2017 Apr-Jun;16(2):169-171. doi: 10.4103/1450-1147.203074.

Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.

Semin Nucl Med. 2011 Sep;41(5):364-8. doi: 10.1053/j.semnuclmed.2011.03.003.

Drug therapy alternatives in the treatment of thyroid cancer.

Drugs. 1998 Jun;55(6):801-12. doi: 10.2165/00003495-199855060-00007.

Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma.

J Endocrinol Invest. 1997 Oct;20(9):527-30. doi: 10.1007/BF03348014.

Accumulation of thallium-201 in medullary thyroid cancer with negative serum calcitonin and carcinoembryonic antigens: a case report.

Ann Nucl Med. 1993 Feb;7(1):53-6. doi: 10.1007/BF03164793.

[Malignant adrenal pheochromocytoma--problems in evaluating clinical diagnosis and morphologic extent].

Langenbecks Arch Chir. 1993;378(1):37-40. doi: 10.1007/BF00207993.

Localization of hepatic metastases by radiolabelled anti-carcinoembryonic antigen antibody and meta-iodobenzylguanidine in a patient with medullary thyroid carcinoma.

Eur J Nucl Med. 1993 Jun;20(6):551-4. doi: 10.1007/BF00175167.

Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

Eur J Nucl Med. 1994 Jun;21(6):561-81. doi: 10.1007/BF00173045.

Scintigraphic detection of recurrence of medullary thyroid cancer.

Ann Nucl Med. 1995 May;9(2):101-4. doi: 10.1007/BF03164975.

131I-metaiodobenzylguanidine therapy for malignant pheochromocytoma.

Ann Nucl Med. 1994 May;8(2):133-7. doi: 10.1007/BF03165018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验